Universitätsklinikum Aachen

Aachen D-52074

9 studies enrolling now · 22 studies all time

What they study most

Acute Coronary Syndrome, Acute Kidney Injury, Acute Kidney Injury Due to Sepsis, Alpha1-Antitrypsin Deficiency, Atherosclerotic Cardiovascular Disease (ASCVD), Carcinoma, Renal Cell, Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, Chronic Phase, Colitis, Ulcerative, Coronary Artery Disease, Crohn Disease, Depressive Disorder, Major

Studies at this site

• Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
• A Study of Brenipatide in Adult Participants With Major Depressive Disorder — Recruiting now
• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
• A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) — Recruiting now
• A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems — Recruiting now
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures — Recruiting now
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) — Recruiting now
• A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL) — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease — Completed
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC) — Completed
• A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD) — Completed
• The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study — Running, not enrolling
• A Longitudinal Observational Study of the Natural History and Management of Patients With HCC — Running, not enrolling
• (Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI — Stopped early
• A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) — Completed
• ABRE Clinical Study of the Abre Venous Self-expanding Stent System — Completed
• Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis — Completed
• PRESSUREwire Study — Completed
• Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury — Completed